Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies

Developmental Medicine and Child Neurology

Volumn 58, Issue 8, 2016, Pages 836-841

  Hacohen, Yael ^a   Nishimoto, Yukihiro ^b   Fukami, Yuki ^c   Lang, Bethan ^a   Waters, Patrick ^a   Lim, Ming J ^a,d   Yuki, Nobuhiro ^c,e   Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b National Hospital Organization   (Japan)

^c Dept Medicine Endocrinol Diabet   (Singapore)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AQUAPORIN 4; AUTOANTIBODY; AXONIN 1; GLYCINE RECEPTOR; IMMUNOGLOBULIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREDNISOLONE; VOLTAGE GATED POTASSIUM CHANNEL;

ADOLESCENT; ARTICLE; BICKERSTAFF BRAINSTEM ENCEPHALITIS; BRAINSTEM ENCEPHALITIS; CHILD; DEMYELINATING DISEASE; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAY MATTER; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WHITE MATTER;

EID: 84978197063     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.13090     Document Type: Article

References (26)

1. Tan IL, Mowry EM, Steele SU, et al. Brainstem encephalitis: etiologies, treatment, and predictors of outcome. J Neurol 2013; 260: 2312–19.
2. Ratelade J, Bennett JL, Verkman AS. Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS ONE 2011; 6: e27412.
3. Chang T, Alexopoulos H, Pettingill P, et al. Correction: immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss. PLoS ONE 2013; 8: e72921.
4. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63–74.
5. Kremer L, Mealy M, Jacob A, et al. Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Mult Scler 2014; 20: 843–47.
6. Carvajal-Gonzalez A, Leite MI, Waters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 2014; 137: 2178–92.
7. Tobin WO, Lennon VA, Komorowski L, et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology 2014; 83: 1797–803.
8. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10: 835–44.
9. Krupp LB, Banwell B, Tenembaum S. International pediatric MSSG. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7–12.
10. Bigi S, Fischer U, Wehrli E, et al. Acute ischemic stroke in children versus young adults. Ann Neurol 2011; 70: 245–54.
11. Irani SR, Bera K, Waters P, et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133: 1655–67.
12. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis. Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734–48.
13. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012; 78: 665–71; discussion 669.
14. Hacohen Y, Absoud M, Deiva K, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm 2015; 2: e81.
15. Odaka M, Yuki N, Yamada M, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003; 126: 2279–90.
16. Hacohen Y, Singh R, Rossi M, et al. Clinical relevance of voltage-gated potassium channel-complex antibodies in children. Neurology 2015; 85: 967–75.
17. Irani SR, Gelfand JM, Al-Diwani A, Vincent A. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 2014; 76: 168–84.
18. Bickerstaff ER, Cloake PC. Mesencephalitis and rhombencephalitis. Br Med J 1951; 2: 77–81.
19. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci 1993; 118: 83–87.
20. Merwick A, Dalmau J, Delanty N. Bickerstaff encephalitis and atypical features – Bickerstaff's papers revisited. J Neurolog Sci 2014; 341: 173.
21. Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013; 84: 748–55.
22. Hacohen Y, Absoud M, Woodhall M, et al. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry 2014; 85: 456–61.
23. Hacohen Y, Absoud M, Hemingway C, et al. NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroimmunol Neuroinflamm 2014; 1: e2.
24. Titulaer MJ, Hoftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 2014; 75: 411–28.
25. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 2015; 86: 265–72.
26. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177–89.